- Report
- May 2025
- 182 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- July 2025
- 285 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- July 2025
- 94 Pages
Global
From €5134EUR$5,850USD£4,442GBP
- Report
- October 2024
- 237 Pages
Global
From €6977EUR$7,950USD£6,037GBP
- Report
- October 2024
- 244 Pages
Global
From €6977EUR$7,950USD£6,037GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Report
- May 2024
- 137 Pages
Global
From €5704EUR$6,499USD£4,935GBP
- Report
- May 2024
- 133 Pages
Global
From €5704EUR$6,499USD£4,935GBP
- Report
- August 2022
- 100 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- February 2023
- 220 Pages
Global
From €6582EUR$7,500USD£5,695GBP
- Report
- February 2022
- 37 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Report
- May 2023
- 128 Pages
Global
From €3500EUR$4,272USD£3,134GBP
- Report
- July 2022
- 63 Pages
Global
From €1755EUR$2,000USD£1,519GBP
- Book
- January 2013
- 230 Pages
Nitroglycerin is a cardiovascular drug used to treat angina, a condition caused by reduced blood flow to the heart. It works by dilating the blood vessels, allowing more blood to flow to the heart and reducing the chest pain associated with angina. Nitroglycerin is available in various forms, including tablets, ointments, sprays, and patches. It is also available in combination with other drugs, such as aspirin and beta-blockers. Nitroglycerin is generally well-tolerated, but side effects can include headaches, dizziness, and flushing.
Nitroglycerin is widely used in the treatment of angina and is available from many pharmaceutical companies. Some of the major companies in the market include Pfizer, GlaxoSmithKline, Merck, Novartis, and Sanofi. Show Less Read more
